Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49)
- 1 February 2020
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 125 (4) , 485-490
Abstract
No abstract availableKeywords
Funding Information
- Genentech
This publication has 19 references indexed in Scilit:
- Relation of Hyperemic Epicardial Flow to Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction Receiving Fibrinolytic TherapyThe American Journal of Cardiology, 2008
- Intracoronary Streptokinase after Primary Percutaneous Coronary InterventionNew England Journal of Medicine, 2007
- Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trialThe Lancet, 2006
- Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarctionEuropean Heart Journal, 2002
- Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial InfarctionCirculation, 2001
- Intracoronary recombinant tissue-type plasminogen activator (rt-PA)Coronary Artery Disease, 1996
- TIMI Frame CountCirculation, 1996
- Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trialsThe American Journal of Cardiology, 1992
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985